#Lenacapavir #FDA "Such strong data usually bode well for prompt review and approval, but it is unclear how FDA reorganization and staff layoffs under the new presidential administration could affect the timeline." @lizhighleyman.bsky.social
https://www.poz.com/article/gilead-aims-launch-twiceyearly-prep-summer
https://www.poz.com/article/gilead-aims-launch-twiceyearly-prep-summer
Comments